BMJ Best Practice

参考文献

关键文献

Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63:e112-e146.

Limper AH, Knox KS, Sarosi GA, et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183:96-128.

参考文章

1.  Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. 1990;3:247-268.

2.  Galgiani J. Coccidioides immitis. In: Mandel GL, Bennett JE, Dolin RE, eds. Principles and practice of infectious diseases. 6th ed. New York: Churchill Livingstone; 2005:2746-2757.

3.  Sunenshine RH, Anderson S, Erhart L, et al. Public health surveillance for coccidioidomycosis in Arizona. Ann NY Acad Sci. 2007;1111:96-102.

4.  Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63:e112-e146.

5.  Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases - United States, 2004. MMWR Morb Mortal Wkly Rep. 2006;53:1-79.

6.  Centers for Disease Control and Prevention. Valley fever (coccidioidomycosis) statistics. June 2017. https://www.cdc.gov (last accessed 15 September 2017).

7.  Ruddy BE, Mayer AP, Ko MG, et al. Coccidioidomycosis in African Americans. Mayo Clin Proc. 2011;86:63-69.

8.  Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med. 2006;119:993.

9.  Spinello IM, Johnson RH, Baqi S. Coccidioidomycosis in pregnancy: a review. Ann NY Acad Sci. 2007;1111:358-364.

10.  Fisher MC, Koenig GL, White TJ, et al. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002;94:73-84.

11.  Hector RF, Laniado-Laborin R. Coccidioidomycosis: a fungal disease of the Americas. PLoS Med. 2005;2:e2.

12.  Kirkland T, Fierer J. Coccidioidomycosis: a reemerging infectious disease. Emerg Infect Dis. 1996;3:192-199.

13.  Anstead GM, Graybill JR. Coccidioidomycosis. Infect Dis Clin North Am. 2006;20:621-643.

14.  Ampel MA. Coccidiodomycosis in persons infected with HIV type 1. Clin Infect Dis. 2005;41:1174-1178.

15.  Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33:1536-1544.

16.  Glenn TJ, Blair JE, Adams RH. Coccidioidomycosis in hematopoietic stem cell transplant recipients. Med Mycol. 2005;43:705-710.

17.  Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006;119:964-969.

18.  Crum NF, Lederman ER, Stafford CM, et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). 2004;83:149-175.

19.  Valdivia L, Nix D, Wright M, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis. 2006;12:958-962.

20.  Blair JE, Coakley B, Santelli AC, et al. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006;162:317-324.

21.  Saubolle MA. Laboratory aspects in the diagnosis of coccidioidomycosis. Ann N Y Acad Sci. 2007;1111:301-314.

22.  Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical and diagnostic aspects of coccidioidomycosis. J Clin Microbiol. 2007;45:26-30.

23.  Batra P, Batra RS. Thoracic coccidioidomycosis. Semin Roentgenol. 1996;31:28-44.

24.  Zeppa MA, Laorr A, Greenspan A, et al. Skeletal coccidioidomycosis: imaging findings in 19 patients. Skeletal Radiol. 1996;25:337-343.

25.  Wheat LJ, Kauffman CA. Histoplasmosis. Infect Dis Clin North Am. 2003;17:1-19.

26.  Chapman SW. Blastomyces dermatiditis. In: Mandel GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. New York: Churchill Livingstone; 2005:448-459.

27.  Limper AH, Knox KS, Sarosi GA, et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183:96-128.

28.  Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis. 2005;41:1217-1223.

29.  Prabhu RM, Bonnell M, Currier BL, et al. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004;39:e74-e77.

30.  Caraway NP, Fanning CV, Stewart JM, et al. Coccidioidomycosis osteomyelitis masquerading as a bone tumor: a report of 2 cases. Acta Cytol. 2003;47:777-782.

31.  Stevens DA, Rendon A, Gaona Flores V, et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest. 2007;132:952-958.

32.  Catanzaro A, Cloud GA, Stevens DA, et al. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis. 2007;45:562-568.

33.  Rachwalski EJ, Wieczorkiewicz JT, Scheetz MH. Posaconazole: an oral triazole with an extended spectrum of activity. Ann Pharmacother. 2008;42:1429-1438.

34.  Kim MM, Vikram HR, Kusne S, et al. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis. 2011;53:1060-1066.

35.  Blair JE. State-of-the-art treatment of coccidioidomycosis: skin and soft-tissue infections. Ann N Y Acad Sci. 2007;1111:411-421.

36.  Blair JE. State-of-the-art treatment of coccidioidomycosis: skeletal infections. Ann N Y Acad Sci. 2007;1111:422-433.

37.  Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med. 2000;133:676-686.

38.  Goldstein EJ, Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis. 2006;42:103-107.

使用此内容应接受我们的免责声明。